MICHAEL ITTMANN to Neoplasm Grading
This is a "connection" page, showing publications MICHAEL ITTMANN has written about Neoplasm Grading.
Connection Strength
0.211
-
Moving Beyond Gleason Scoring. Arch Pathol Lab Med. 2019 05; 143(5):565-570.
Score: 0.137
-
Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties. Oncogene. 2016 11 17; 35(46):5963-5976.
Score: 0.028
-
Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia. Prostate Cancer Prostatic Dis. 2013 Dec; 16(4):292-300.
Score: 0.023
-
Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy. J Mol Diagn. 2013 Mar; 15(2):270-9.
Score: 0.022